Changqing Ma, MD, PhD
Assistant Professor of Pathology
Dr. Ma is a member of the Division of Anatomic Pathology with a subspecialty interest in gastrointestinal pathology.
Department of Pathology
Presbyterian University Hospital
200 Lothrop Street
Pittsburgh, PA 15213
Office Telephone: 412-647-0282
- MD - Beijing Medical University, 1998
- PhD - University of Pittsburgh, 2005
Clinical ExpertiseDr. Ma is a surgical pathologist with subspecialty training in gastrointestinal, liver and pancreatobiliary pathology. Her diagnostic expertise includes both neoplastic and non-neoplastic diseases of the gastrointestinal system, liver, biliary tract and pancreas.
Research InterestsDr. Ma is interested in the clinical, translational, and molecular characterization of gastrointestinal and pancreatic diseases to improve diagnosis, accurate prognostication, and treatment of these diseases.
SpecialtiesGastrointestinal and Pancreatobiliary Pathology
- Board Certified in Anatomic Pathology and Clinical Pathology
Awards and Honors
- Outstanding Report Award, APIII Conference, Pittsburgh, PA USA, 2002
- Travel Fellowship Award, International Society of Computational Biology, Edmonton, Canada, 2002
- Resident Research Committee, Department of Pathology, Washington University in St. Louis, 2012
- Pathologist-In-Training Award, Hans Popper Hepatopathology Society, USCAP Annual Meeting, 2013
Selected PublicationsMa C, Giardiello FM, and Montgomery EA. Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are often associated with foveolar, intestinal and pyloric differentiation. Accepted for publication (Am J Surg Pathol)
Ma C, Limketkai BN, and Montgomery EA. Recently highlighted non-neoplastic pathologic entities of the upper gastrointestinal tract and their clinical significance. Accepted for publication (Gastrointest Endosc)
Ma C, Montgomery EA, and Lam-Himlin D. Docetaxel therapy induced diffuse atypia and mitotic arrest mimicking dysplasia - a diagnostic pitfall. Diagnostic Histopathology 2014, 20, 46-47.
Ma C and Gronoswski AM. Laboratory workup of well-differentiated pancreatic neuroendocrine tumors. Clinical Chem ASCP Case Reports series. May 2014.
Ma C, Crippin JS, Chapman WC, Korenblat K, Vachharajani N, Gunter KL, and Brunt EM. Vascular alterations in explant hepatectomies from patients with hepatopulmonary syndrome or portopulmonary hypertension. Liver Transpl. 2013, 19(7):741-50; PMID:23463612
Ma C, Gronoswski AM, and Scott MG. Transferrin/log(ferritin) ratio: a self-fulfilling prophecy when iron deficiency is defined by serum ferritin concentration. Clin Chem Lab Med. 2013, 51(5):e85-86; PMID:23152417
Dehdashti F, Grigsby PW, Myerson RJ, Parikh PJ, Nalbantoglu I, Ma C, and Siegel BA. Positron emission tomography with [18F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study. Mol Imaging Biol 2013, 15(1):106-113; PMID:22684813
Ma C and Brunt EM. Histopathologic evaluation of liver biopsy for cirrhosis. Adv Anat Pathol 2012, 19(4):220-230; PMID:22692285
Ma C and Lewis J. Small biopsy specimens reliably indicate p16 expression status of oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012, 6(2):208-215; PMID:22203477
Porembka MR, Hawkins WG, Linehan DC, Gao F, Ma C, Brunt EM, and Strasberg SM. Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas. HPB (Oxford) 2011, 13(9):633-642; PMID:21843264
Neely RJ, Brose MS, Gray CM, McCorkell KA, Leibowitz JM, Ma C, Rothstein JL, and May MJ. The RET/PTC3 oncogene activates classical NF-kappaB by stabilizing NIK. Oncogene 2011, 30(1):87-96; PMID:20818435